A novel human HER2-derived peptide homologous to the mouse K(d)-restricted tumor rejection antigen can induce HLA-A24-restricted cytotoxic T lymphocytes in ovarian cancer patients and healthy individuals.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples